Skip to main content Accessibility help
×
Home

An exploration of cognitive subgroups in Alzheimer’s disease

  • JULIE E. DAVIDSON (a1) (a2), MICHAEL C. IRIZARRY (a3), BETHANY C. BRAY (a4), SALLY WETTEN (a2), NICHOLAS GALWEY (a2), RACHEL GIBSON (a2), MICHAEL BORRIE (a5), RICHARD DELISLE (a6), HOWARD H. FELDMAN (a7) (a8), GING-YUEK HSIUNG (a7), LUIS FORNAZZARI (a9), SERGE GAUTHIER (a10), DANILO GUZMAN (a11), INGE LOY-ENGLISH (a11), RON KEREN (a12), ANDREW KERTESZ (a13), PETER ST. GEORGE-HYSLOP (a12), JOHN WHERRETT (a12) and ANDREAS U. MONSCH (a1)...

Abstract

Heterogeneity is observed in the patterns of cognition in Alzheimer’s disease (AD). Such heterogeneity might suggest the involvement of different etiological pathways or different host responses to pathology. A total of 627 subjects with mild/moderate AD underwent cognitive assessment with the Mini-Mental State Examination (MMSE) and the Dementia Rating Scale-2 (DRS-2). Latent class analysis (LCA) was performed on cognition subscale data to identify and characterize cognitive subgroups. Clinical, demographic, and genetic factors were explored for association with class membership. LCA suggested the existence of four subgroups; one group with mild and another with severe global impairment across the cognitive domains, one group with primary impairments in attention and construction, and another group with primary deficits in memory and orientation. Education, disease duration, age, Apolipoprotein E-ε4 (APOE ε4) status, gender, presence of grasp reflex, white matter changes, and early or prominent visuospatial impairment were all associated with class membership. Our results support the existence of heterogeneity in patterns of cognitive impairment in AD. Our observation of classes characterized by predominant deficits in attention/construction and memory respectively deserves further exploration as does the association between membership in the attention/construction class and APOE ε4 negative status. (JINS, 2010, 16, 233–243.)

Copyright

Corresponding author

*Correspondence and reprint requests to: Julie Davidson, GlaxoSmithKline R&D, New Frontiers Science Park, Third Avenue, Harlow, Essex, CM19 5AW, UK. E-Mail: julie.e.davidson@gsk.com

References

Hide All
Alladi, S., Xuereb, J., Bak, T., Nestor, P., Knibb, J., Patterson, K., et al. . (2007). Focal cortical presentations of Alzheimer’s disease. Brain, 130, 26362645.
American Psychiatric Association. (1994). Diagnostic and Statistical Manual of Mental Disorders (4th ed.). Washington, DC: American Psychiatric Association.
Bondi, M.W., Salmon, D.P., Monsch, A.U., Galasko, D., Butters, N., Klauber, M.R., et al. . (1995). Episodic memory changes are associated with the APOE-epsilon 4 allele in nondemented older adults. Neurology, 45, 22032206.
Braak, H., & Braak, E. (1991). Neuropathological staging of Alzheimer-related changes. Acta Neuropathologica, 82, 239259.
Bretsky, P., Guralnik, J.M., Launer, L., Albert, M., Seeman, T.E.; MacArthur Studies of Successful Aging. (2003). The role of APOE-epsilon4 in longitudinal cognitive decline: MacArthur Studies of Successful Aging. Neurology, 60, 10771081.
den Heijer, T., Oudkerk, M., Launer, L.J., van Duijn, C.M., Hofman, A., & Breteler, M.M. (2002). Hippocampal, amygdalar, and global brain atrophy in different apolipoprotein E genotypes. Neurology, 59, 746748.
Dubois, B., Feldman, H.H., Jacova, C., DeKosky, S.T., Barberger-Gateau, P., Cummings, J., et al. . (2007). Research criteria for the diagnosis of Alzheimer’s disease: Revising the NINCDS-ADRDA criteria. Lancet Neurology, 6, 734746.
Fisher, N.J., Rourke, B.P., Bieliauskas, L., Giordani, B., Berent, S., & Foster, N.L. (1996). Neuropsychological subgroups of patients with Alzheimer’s disease. Journal of Clinical and Experimental Neuropsychology, 18, 349370.
Fisher, N.J., Rourke, B.P., & Bieliauskas, L.A. (1999). Neuropsychological subgroups of patients with Alzheimer’s disease: An examination of the first 10 years of CERAD data. Journal of Clinical and Experimental Neuropsychology, 21, 488518.
Folstein, M.F., Folstein, S.E., & McHugh, P.R. (1975). “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189198.
Galton, C.J., Patterson, K., Xuereb, J.H., & Hodges, J.R. (2000). Atypical and typical presentations of Alzheimer’s disease: A clinical, neuropsychological, neuroimaging and pathological study of 13 cases. Brain, 123(Pt 3), 484498.
Greenwood, P.M., Lambert, C., Sunderland, T., & Parasuraman, R. (2005). Effects of apolipoprotein E genotype on spatial attention, working memory, and their interaction in healthy, middle-aged adults: Results From the National Institute of Mental Health’s BIOCARD study. Neuropsychology, 19, 199211.
Hatcher, L (1994). A Step-by-Step Approach to using SAS for Factor Analysis and Structural Equation Modelling. Cary, NC: SAS Institute Inc.
Hodges, J.R. (2006). Alzheimer’s centennial legacy: Origins, landmarks and the current status of knowledge concerning cognitive aspects. Brain, 129, 28112822.
Jacobs, D., Sano, M., Marder, K., Bell, K., Bylsma, F., Lafleche, G., et al. . (1994). Age at onset of Alzheimer’s disease: Relation to pattern of cognitive dysfunction and rate of decline. Neurology, 44, 12151220.
Johnson, J.K., Head, E., Kim, R., Starr, A., & Cotman, C.W. (1999). Clinical and pathological evidence for a frontal variant of Alzheimer disease [see comment]. Archives of Neurology, 56, 12331239.
Jurica, P.J., Leitten, C.L., & Mattis, S. (2001). Dementia Rating Scale-2: Professional Manual. Lutz, Fl: Psychological Assessment Resources.
Kanne, S.M., Balota, D.A., Storandt, M., McKeel, D.W. Jr., & Morris, J.C. (1998). Relating anatomy to function in Alzheimer’s disease: Neuropsychological profiles predict regional neuropathology 5 years later. Neurology, 50, 979985.
Lanza, S.T., Collins, L.M., Lemmon, D.R., & Schafer, J.L. (2007a). PROC LCA: A SAS procedure for latent class analysis. Struct Equ Model, 14, 671694.
Lanza, S.T., Lemmon, D.R., Schafer, J.L., & Collins, L.M. (2007b). Proc LCA & Proc LTA User’s Guide Version 1.1.3 beta. State College, PA: The Methodology Center, The Pennsylvania State University.
Li, H., Wetten, S., Li, L., St Jean, P.L., Upmanyu, R., Surh, L., et al. . (2008). Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease. Archives of Neurology, 65, 4553.
Lo, Y., Mendell, N.R., & Rubin, D.B. (2001). Testing the number of components in a normal mixture. Biometrika, 88, 767778.
Marra, C., Bizzarro, A., Daniele, A., De Luca, L., Ferraccioli, M., Valenza, A., et al. . (2004). Apolipoprotein E epsilon4 allele differently affects the patterns of neuropsychological presentation in early- and late-onset Alzheimer’s disease patients. Dementia and Geriatric Cognitive Disorders, 18, 125131.
Martin, A., Brouwers, P., Lalonde, F., Cox, C., Teleska, P., Fedio, P., et al. . (1986). Towards a behavioral typology of Alzheimer’s patients. Journal of Clinical and Experimental Neuropsychology, 8, 594610.
Mattis, S. (1976). Mental status examination for organic mental syndrome in the elderly patient. In Geriatric Psychiatry: A Handbook for Psychiatrists and Primary Care Physicians (pp. 77121). New York: Grune and Stratton.
McCutcheon, A.L. (1987). Latent Class Analysis. Newbury Park: Sage Publications, Inc.
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E.M. (1984). Clinical diagnosis of Alzheimer’s disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology, 34, 939944.
Muthen, L.K., & Muthen, B.O. (2007). Mplus User’s Guide. (5th ed.). Los Angeles, CA: Muthen & Muthen.
Nylund, K.L., Asparouhov, T., & Muthén, B.O. (2007). Deciding on the number of classes in latent class analysis and growth mixture modeling: A Monte Carlo simulation study. Struct Equ Model, 14, 535569.
Pappas, B.A., Bayley, P.J., Bui, B.K., Hansen, L.A., & Thal, L.J. (2000). Choline acetyltransferase activity and cognitive domain scores of Alzheimer’s patients. Neurobiology of Aging, 21, 1117.
Petersen, R.C. (1998). Clinical subtypes of Alzheimer’s disease [Review]. Dementia & Geriatric Cognitive Disorders, 9(Suppl. 3), 1624.
Reisberg, B., Ferris, S.H., de Leon, M.J., & Crook, T. (1982). The Global Deterioration Scale for assessment of primary degenerative dementia. American Journal of Psychiatry, 139, 11361139.
Schott, J.M., Ridha, B.H., Crutch, S.J., Healy, D.G., Uphill, J.B., Warrington, E.K., et al. . (2006). Apolipoprotein e genotype modifies the phenotype of Alzheimer disease. Archives of Neurology, 63, 155156.
Schwartz, G. (1978). Estimating the dimension of a model. Annals of Statistics, 6, 497511.
Sevush, S., Leve, N., & Brickman, A. (1993). Age at disease onset and pattern of cognitive impairment in probable Alzheimer’s disease. Journal of Neuropsychiatry and Clinical Neurosciences, 5, 6672.
Sevush, S., Peruyera, G., Bertran, A., & Cisneros, W. (2003). A three-factor model of cognition in Alzheimer disease. Cognitive and Behavioral Neurology, 16, 110117.
Smith, G.E., Bohac, D.L., Waring, S.C., Kokmen, E., Tangalos, E.G., Ivnik, R.J., et al. . (1998). Apolipoprotein E genotype influences cognitive ‘phenotype’ in patients with Alzheimer’s disease but not in healthy control subjects. Neurology, 50, 355362.
Snowden, J.S., Stopford, C.L., Julien, C.L., Thompson, J.C., Davidson, Y., Gibbons, L., et al. . (2007). Cognitive phenotypes in Alzheimer’s disease and genetic risk. Cortex, 43, 835845.
Stopford, C.L., Snowden, J.S., Thompson, J.C., & Neary, D. (2008). Variability in cognitive presentation of Alzheimer’s disease. Cortex, 44, 185195.
Tombaugh, T.N., & McIntyre, N.J. (1992). The mini-mental state examination: A comprehensive review [see comment] [Review]. Journal of the American Geriatrics Society, 40, 922935.
Tsai, S.J., Gau, Y.T., Liu, M.E., Hsieh, C.H., Liou, Y.J., & Hong, C.J. (2008). Association study of brain-derived neurotrophic factor and apolipoprotein E polymorphisms and cognitive function in aged males without dementia. Neuroscience Letters, 433, 158162.
van der Flier, W.M., Schoonenboom, S.N., Pijnenburg, Y.A., Fox, N.C., & Scheltens, P. (2006). The effect of APOE genotype on clinical phenotype in Alzheimer disease [see comment]. Neurology, 67, 526527.
von Gunten, A., Bouras, C., Kovari, E., Giannakopoulos, P., & Hof, P.R. (2006). Neural substrates of cognitive and behavioral deficits in atypical Alzheimer’s disease [Review]. Brain Research Reviews, 51, 176211.
Voyer, D., Voyer, S., & Bryden, M.P. (1995). Magnitude of sex differences in spatial abilities: A meta-analysis and consideration of critical variables. Psychological Bulletin, 117, 250270.
Zehnder, A.E., Blasi, S., Berres, M., Spiegel, R., & Monsch, A.U. (2007). Lack of practice effects on neuropsychological tests as early cognitive markers of Alzheimer disease? American Journal of Alzheimer’s Disease and other Dementias, 22, 416426.

Keywords

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed